A therapeutic rationale is proposed for the treatment of inflammatory diseases, such as psoriasis and inflammatory bowel diseases (IBD), by selective targeting of TYK2. Hit triage, following a high-throughput screen for TYK2 inhibitors, revealed pyridine 1 as a promising starting point for lead identification. Initial expansion of 3 separate regions of the molecule led to eventual identification of cyclopropyl amide 46, a potent lead analog with good kinase selectivity, physicochemical properties, and pharmacokinetic profile. Analysis of the binding modes of the series in TYK2 and JAK2 crystal structures revealed key interactions leading to good TYK2 potency and design options for future optimization of selectivity.
Keywords: 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride; 2-(7-aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate; 4-(N,N-dimethylamino)pyridine; ADME; AcOH; Boc; CDCl(3); Crystal structure; DCE; DCM; DMAP; DMF; DMSO; DMSO-d(6); DTT; EDCI; ESI; HATU; HOBt; Hit to lead; IV; Immunology; Janus family kinase; Kinase inhibitor; LCMS; LogD(7.4); MCT; MDCK; Madin–Darby canine kidney cells; P(app); PO; Ph; SCX-2; SFC; Structure–activity relationship; TCEP; TFA; THF; TLC; TYK2BME; Tf; absorption, distribution, metabolism, and excretion; acetic acid; apparent permeability; aq.; aqueous; by mouth; deuterated DMSO; deuterated chloroform; dichloroethane; dichloromethane; dimethylformamide; dimethylsulfoxide; dithiothreitol; electrospray ionization; h; hour; hydroxybenzotriazole; intravenous; liquid chromatography–mass spectrometry; log of partition coefficient between octanol and pH(7.4) aqueous buffer; methyl cellulose/tween; p-TsOH; para-toluenesulfonic acid; phenyl; pre-packed Isolute(®) silica-based sorbent with a chemically bonded propylsulfonic acid functional group; supercritical fluid chromatography; tert-butyl carbamate; tetrahydrofuran; thin layer chromatography; trifluoroacetic acid; trifluorosulfonate; tris(2-carboxyethyl)phosphine; β-mercaptoethanol.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.